Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Arterial and venous cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), are genetically correlated. Interrogating underlying mechanisms may shed light on disease mechanisms. In this study, we aimed to identify (1) epidemiological and (2) causal, genetic relationships between metabolites and CAD, PAD, and VTE.METHODS:We used metabolomic data from 95 402 individuals in the UK Biobank, excluding individuals with prevalent cardiovascular disease. Cox proportional-hazards models estimated the associations of 249 metabolites with incident disease. Bidirectional 2-sample Mendelian randomization (MR) estimated the causal effects between metabolites and outcomes using genome-wide association summary statistics for metabolites (n=118 466 from the UK Biobank), CAD (n=184 305 from CARDIoGRAMplusC4D 2015), PAD (n=243 060 from the Million Veterans Project), and VTE (n=650 119 from the Million Veterans Project). Multivariable MR was performed in subsequent analyses.RESULTS:We found that 196, 115, and 74 metabolites were associated (P<0.001) with CAD, PAD, and VTE, respectively. Further interrogation of these metabolites with MR revealed 94, 34, and 9 metabolites with potentially causal effects on CAD, PAD, and VTE, respectively. There were 21 metabolites common to CAD and PAD and 4 common to PAD and VTE. Many putatively causal metabolites included lipoprotein traits with heterogeneity across different sizes and lipid subfractions. Small VLDL (very-low-density lipoprotein) particles increased the risk for CAD while large VLDL particles decreased the risk for VTE. We identified opposing directions of CAD and PAD effects for cholesterol and triglyceride concentrations within HDLs (high-density lipoproteins). Subsequent sensitivity analyses including multivariable MR revealed several metabolites with robust, potentially causal effects of VLDL particles on CAD.CONCLUSIONS:While common vascular conditions are associated with overlapping metabolomic profiles, MR prioritized the role of specific lipoprotein species for potential pharmacological targets to maximize benefits in both arterial and venous beds.

Potential causal relationships between blood metabolites, inflammatory cytokines, and venous thromboembolism

Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis

Large-scale Genetic Correlation Scanning and Causal Association Between Deep Vein Thrombosis and Human Blood Metabolites

Causal Effect of Serum Matrix Metalloproteinase Levels on Venous Thromboembolism: a Mendelian Randomization Study

Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks

The role of inflammatory proteins in regulating the impact of lipid specifications on deep venous thrombosis: a two sample and mediated Mendelian randomization study

Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism

Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis

Proteome-wide Mendelian Randomization Identifies Causal Plasma Proteins in Venous Thromboembolism Development

A Bidirectional two-Sample Mendelian Randomization Study of the Association Between Venous Thromboembolism and Ischaemic Stroke

A phenome-wide approach to identify causal risk factors for deep vein thrombosis

Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study

Pulmonary embolism and 529 human blood metabolites: genetic correlation and two-sample Mendelian randomization study

Causal relationship between human blood metabolites and risk of ischemic stroke: a Mendelian randomization study

Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation

Exploring causal correlations between inflammatory cytokines and varicose veins: A Mendelian randomization analysis

Causality of blood metabolites and metabolic pathways on peripheral arteriosclerosis: a Mendelian randomization study

Genome-wide Association Analysis of Venous Thromboembolism Identifies New Risk Loci and Genetic Overlap with Arterial Vascular Disease

Integrated landscape of plasma metabolism and proteome of patients with post-traumatic deep vein thrombosis

Circulating Adipokine Concentrations and the Risk of Venous Thromboembolism: A Mendelian Randomization and Mediation Analysis

Causality assessment of circulating Vitamin D level on venous thromboembolism: A Mendelian randomization study